Sombrio, Gloresil C.
HRN: 25-78-19 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2024
CEFTRIAXONE 1G (VIAL)
08/28/2024
09/03/2024
IV
2g
Q24
UTI
Waiting Final Action